Trivium Point Advisory’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,624
| Closed | -$310K | – | 363 |
|
|
2026
Q1 | $310K | Sell |
2,624
-1,545
| -37% | -$191K | 0.06% | 233 |
|
|
2025
Q4 | $525K | Sell |
4,169
-6,122
| -59% | -$799K | 0.05% | 236 |
|
|
2025
Q3 | $1.51M | Sell |
10,291
-4,706
| -31% | -$711K | 0.15% | 137 |
|
|
2025
Q2 | $2.34M | Sell |
14,997
-1,318
| -8% | -$209K | 0.25% | 104 |
|
|
2025
Q1 | $2.69M | Sell |
16,315
-1,938
| -11% | -$322K | 0.33% | 87 |
|
|
2024
Q4 | $2.97M | Buy |
18,253
+1,378
| +8% | +$246K | 0.38% | 81 |
|
|
2024
Q3 | $2.99M | Sell |
16,875
-1,041
| -6% | -$192K | 0.42% | 78 |
|
|
2024
Q2 | $3.11M | Buy |
17,916
+1,556
| +10% | +$259K | 0.46% | 66 |
|
|
2024
Q1 | $2.77M | Buy |
16,360
+1,554
| +10% | +$291K | 0.6% | 53 |
|
|
2023
Q4 | $2.92M | Buy |
14,806
+304
| +2% | +$53.8K | 0.71% | 46 |
|
|
2023
Q3 | $2.47M | Buy |
14,502
+126
| +0.9% | +$22.9K | 0.68% | 49 |
|
|
2023
Q2 | $2.48M | Sell |
14,376
-6
| -0% | -$1.04K | 0.67% | 43 |
|
|
2023
Q1 | $2.39M | Buy |
14,382
+610
| +4% | +$100K | 0.65% | 48 |
|
|
2022
Q4 | $2.03M | Buy |
13,772
+150
| +1% | +$22.2K | 0.59% | 58 |
|
|
2022
Q3 | $2.08M | Buy |
13,622
+255
| +2% | +$42.6K | 0.64% | 45 |
|
|
2022
Q2 | $2.39M | Sell |
13,367
-666
| -5% | -$115K | 0.72% | 41 |
|
|
2022
Q1 | $2.69M | Sell |
14,033
-5,211
| -27% | -$1.03M | 0.6% | 56 |
|
|
2021
Q4 | $4.7M | Buy |
19,244
+25
| +0.1% | +$5.48K | 0.98% | 26 |
|
|
2021
Q3 | $3.83M | Buy |
19,219
+540
| +3% | +$109K | 0.91% | 27 |
|
|
2021
Q2 | $3.48M | Buy |
18,679
+2,296
| +14% | +$399K | 0.87% | 28 |
|
|
2021
Q1 | $2.58M | Buy |
16,383
+929
| +6% | +$147K | 0.7% | 37 |
|
|
2020
Q4 | $2.58M | Buy |
15,454
+386
| +3% | +$62.8K | 0.75% | 30 |
|
|
2020
Q3 | $2.49M | Buy |
15,068
+14
| +0.1% | +$2.15K | 0.88% | 29 |
|
|
2020
Q2 | $2.09M | Buy |
15,054
+1,769
| +13% | +$231K | 0.83% | 34 |
|
|
2020
Q1 | $1.69M | Sell |
13,285
-486
| -4% | -$64K | 0.87% | 40 |
|
|
2019
Q4 | $1.82M | Buy |
13,771
+159
| +1% | +$19.8K | 0.71% | 51 |
|
|
2019
Q3 | $1.72M | Sell |
13,612
-1,667
| -11% | -$201K | 0.79% | 51 |
|
|
2019
Q2 | $1.73M | Buy |
15,279
+154
| +1% | +$16.1K | 0.77% | 51 |
|
|
2019
Q1 | $1.52M | Buy |
15,125
+480
| +3% | +$43.6K | 0.71% | 58 |
|
|
2018
Q4 | $1.25M | Buy |
+14,645
| New | +$1.32M | 0.76% | 62 |
|
Other funds holding ZTS
Trivium Point Advisory's ZTS Position: Q2 2026 in Review
Trivium Point Advisory sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 2,624 shares — an estimated $310K sold.
Trivium Point Advisory first reported a position in ZTS in Q4 2018 and held it in 30 quarters. The position peaked at $4.7M in Q4 2021. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Trivium Point Advisory reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
- Trivium Point Advisory sold 2,624 Zoetis shares in Q2 2026, an estimated $310K.
- Trivium Point Advisory first reported a position in Zoetis in Q4 2018 and held it in 30 quarters.
- Trivium Point Advisory's Zoetis position peaked at $4.7M in Q4 2021.
- 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Trivium Point Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.